Clinical Trial Update: Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study. [Phase 2]

View source ↗

Summary

A Phase 2, single-arm trial evaluating apatinib as second-line therapy for advanced osteosarcoma and soft tissue sarcomas; the status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Osteosarcoma, Advanced | Phase 2 | Status: UNKNOWN